196 related articles for article (PubMed ID: 8066683)
1. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
Amemiya H; Suzuki S; Hayashi R; Nakatani T
Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
[No Abstract] [Full Text] [Related]
2. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
[No Abstract] [Full Text] [Related]
3. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
[No Abstract] [Full Text] [Related]
4. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
5. Immunosuppressive therapy using CsA, MZ, steroids, and DSG during the early phase after kidney grafting, with later steroid withdrawal.
Suzuki S; Hayashi R; Nakatani T; Amemiya H
Transplant Proc; 1994 Aug; 26(4):2065-6. PubMed ID: 8066671
[No Abstract] [Full Text] [Related]
6. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
Jiang H; Takahara S; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
[No Abstract] [Full Text] [Related]
7. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
Takahara S; Moutabarrik A; Kokado Y; Kameoka H; Takano Y; Zaid D; Ishibashi M; Sonoda T; Okuyama A
Transplant Proc; 1993 Jun; 25(3):2254-8. PubMed ID: 8516891
[No Abstract] [Full Text] [Related]
8. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H
Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
[No Abstract] [Full Text] [Related]
9. Current advantage of FK 506 in cadaveric kidney transplantation.
Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
[No Abstract] [Full Text] [Related]
10. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
[No Abstract] [Full Text] [Related]
11. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
[No Abstract] [Full Text] [Related]
12. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
[No Abstract] [Full Text] [Related]
13. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
[No Abstract] [Full Text] [Related]
14. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
[No Abstract] [Full Text] [Related]
15. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
16. Chronic rejection of renal allografts with four immunosuppressive regimens.
Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
[No Abstract] [Full Text] [Related]
17. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
Inoue S; Beck Y; Nagao T; Uchida H
Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
[No Abstract] [Full Text] [Related]
18. Long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart-beating donors.
Fukuhara N; Ono Y; Kinukawa T; Hattori R; Nishiyama N; Yamada S; Kamihira O; Ohshima S
Transplant Proc; 2002 Aug; 34(5):1577-9. PubMed ID: 12176492
[No Abstract] [Full Text] [Related]
19. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
20. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
